PMID: 9545712Apr 18, 1998Paper

Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy

Medizinische Klinik
S HarderA Steioff

Abstract

To obtain information on the structure, present activities and decision making process of hospital drug committees in Germany in 1995 a questionnaire with 36 items was designed and sent to 450 hospitals in Germany with more than 400 beds. 143 returned questionnaires could be evaluated. According to hospital size the median value of the annual drug budget 1993 ranged between DM 2.4 Mio for hospitals with less than 500 beds and DM 30.0 Mio for university hospitals with more than 1,000 beds (including blood and blood derived products). In 53% of drug committees a pharmacist held the position of the chairman, followed by medical specialists (32%), (clinical) pharmacologists held this position only in 8% of the hospitals, but in almost 50% of the university hospitals. In most cases all clinical specialties are represented in the drug committee, the number of members ranging between 5 and 40 (median 12). The number of drugs included in the internal drug list ranging between 400 in hospitals with < 500 beds and about 700 in university hospitals was strongly correlated with the number of beds and, interestingly, with the number of drug committee members. Treatment guidelines were implemented mainly for antiinfectives (87%), infusion so...Continue Reading

References

Feb 8, 1975·British Medical Journal·A W BrownA Herxheimer
Dec 5, 1992·Lancet·I Durand-ZaleskiF Lemaire
May 1, 1992·Clinical Pharmacology and Therapeutics·R A BranchJ R Knight
Jan 1, 1992·European Journal of Clinical Pharmacology·B OhmanF Sjöqvist
Jan 6, 1990·BMJ : British Medical Journal·J FeelyP O'Connor
Feb 1, 1990·Journal of Clinical Pharmacy and Therapeutics·C A Sutters
Mar 16, 1987·Klinische Wochenschrift·D Palm
Aug 13, 1988·BMJ : British Medical Journal·J A BakerC A Sutters
Aug 19, 1988·Pharmaceutisch Weekblad. Scientific Edition·T D Rucker
Jul 1, 1982·The American Journal of Medicine·J AvornR Hartley
Oct 1, 1996·Clinical Pharmacology and Therapeutics·A J Atkinson, K Nordstrom
Aug 6, 1993·PharmacoEconomics·P Thürmann, S Harder
Dec 9, 1995·PharmacoEconomics·J Avorn

❮ Previous
Next ❯

Citations

Jan 29, 2014·European Journal of Clinical Pharmacology·Kristina LohmannHanna Marita Seidling

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
P Flatberg
European Journal of Clinical Pharmacology
P ThürmannA Steioff
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
E Haug
© 2022 Meta ULC. All rights reserved